Skip to content
Disclosery

Lamond Capital Partners LLC

Follow

13F filer, CIK 1542550, SAN FRANCISCO, CA

Lamond Capital Partners LLC reported $152,691,000 across 15 holdings for the quarter ended 2014-12-31, in a 13F-HR filed 2015-02-13. Its ten largest share positions make up 90.21% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001542550-15-000002

Period
2014-12-31
Reported value
$153M
Holdings
15
Top 10 weight
90.21%
New
12
Sold out
9

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KITE PHARMA INCnew+365,900$21.1M
INFOBLOX INCadded+722,996$14.6M
BLUEBIRD BIO INCnew+147,380$13.5M
GILDnew+135,870$12.8M
OREXIGEN THERAPEUTICS INCnew+1,891,000$11.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LINKEDIN CORPexited-51,070-$10.6M
AMGNexited-70,000-$9.83M
SUNESIS PHARMACEUTICALS INCexited-1,320,000-$9.43M
KING DIGITAL ENTMT PLCexited-719,006-$9.13M
CIENexited-411,650-$6.88M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2014

Share positions as resolved from 13F-HR 0001542550-15-000002, largest first. % of portfolio is the value over $152,689,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INFOBLOX INCINFOBLOX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: 772,910 shares; 2014Q4: 1,495,906 shares 1,495,906$30.2M19.8%+722,996
KITE PHARMA INCKITE PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 365,900 shares 365,900$21.1M13.82%new
BLUEBIRD BIO INCBLUEBIRD BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 147,380 shares 147,380$13.5M8.85%new
RALLY SOFTWARE DEV CORP COMRALLY SOFTWARE DEV CORP COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: 792,950 shares; 2014Q4: 1,163,626 shares 1,163,626$13.2M8.66%+370,676
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 135,870 shares 135,870$12.8M8.39%newTimeline
OREXIGEN THERAPEUTICS INCOREXIGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 1,891,000 shares 1,891,000$11.5M7.5%new
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 55,005 shares 55,005$10.4M6.82%newTimeline
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 134,230 shares 134,230$9.09M5.95%new
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 91,840 shares 91,840$8.3M5.44%newTimeline
CRMSALESFORCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: 182,040 shares; 2014Q4: 127,970 shares 127,970$7.59M4.97%-54,070Timeline
AOL INCAOL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 128,850 shares 128,850$5.95M3.9%new
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 77,940 shares 77,940$3.42M2.24%newTimeline
RNGRINGCENTRAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 161,424 shares 161,424$2.41M1.58%newTimeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 74,380 shares 74,380$1.75M1.15%newTimeline
SYNAGEVA BIOPHARMA CORPSYNAGEVA BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2013Q1: restricted; 2013Q2: restricted; 2013Q3: restricted; 2013Q4: restricted; 2014Q1: restricted; 2014Q2: restricted; 2014Q3: not reported; 2014Q4: 15,390 shares 15,390$1.43M0.94%new

Sold out in Q4 2014

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LINKEDIN CORPLINKEDIN CORP51,070$10.6Mshares
AMGNAMGEN INC70,000$9.83Mshares
SUNESIS PHARMACEUTICALS INCSUNESIS PHARMACEUTICALS INC1,320,000$9.43Mshares
KING DIGITAL ENTMT PLCKING DIGITAL ENTMT PLC719,006$9.13Mshares
CIENCIENA CORP411,650$6.88Mshares
ZULILY INCZULILY INC105,230$3.99Mshares
FTNTFORTINET INC145,650$3.68Mshares
NIMBLE STORAGE INCNIMBLE STORAGE INC102,514$2.66Mshares
Foundation Medicine IncFoundation Medicine Inc130,053$2.47Mshares

How Q4 2014 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001542550-15-000002 base2015-02-13acceptance time not in the bulk data set